Social:European law on drug precursors

From HandWiki

European law on illicit drug precursors:

The list of 23 substances is identical to list of UN-controlled drug precursors, except for the different categorization and inclusion of stereoisomers in EU Category 1.

List of substances

Category 1 Precursors

  • phenylacetone
  • methyl 2-phenylacetoacetate (MAPA)
  • methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate)
  • 2-methyl-3-phenyloxirane-2-carboxylic acid (BMK glycidic acid)
  • N-acetylanthranilic acid
  • alpha-phenylacetoacetamide (APAA)
  • alpha-phenylacetoacetonitrile (APAAN)
  • isosafrole (cis + trans)
  • 3,4-methylenedioxyphenylpropan-2-one
  • piperonal
  • safrole
  • methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate)
  • 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid)
  • 4-anilino-N-phenethylpiperidine (ANPP)
  • N-phenethyl-4-piperidone (NPP)
  • ephedrine
  • chloroephedrine
  • pseudoephedrine
  • chloropseudoephedrine
  • norephedrine
  • ergometrine
  • ergotamine
  • lysergic acid

The stereoisomeric forms of the substances listed in this Category not being cathine, whenever the existence of such forms is possible.

The salts of the substances listed in this Category whenever the existence of such salts is possible and not being the salts of cathine.

Category 2 Precursors

The salts of the substances listed in this Category whenever the existence of such salts is possible.

Category 3 Precursors

The salts of the substances listed in this Category whenever the existence of such salts is possible and not being the salts of hydrochloric acid and sulphuric acid.

Category 4 Precursors

  • Medicinal products and veterinary medicinal products containing ephedrine or its salts
  • Medicinal products and veterinary medicinal products containing pseudo-ephedrine or its salts

See also

  • List of UN-controlled drug precursors
  • List of US-controlled drug precursors
  • Drug precursors
  • European Council decisions on designer drugs
  • European Monitoring Centre for Drugs and Drug Addiction

References